{"data":{"id":"e0fb85af-5e48-46df-a09f-2e0c573a4c89","title":"OpenAI acquires Orchestra Bio","summary":"OpenAI has acquired Orchestra Bio, a platform that helps biopharma teams coordinate drug development. OpenAI plans to combine Orchestra's team and technology with Rosalind, its AI models and tools for life sciences research. The stated goal is to help scientists make discoveries and get new treatments to patients sooner.","solution":"N/A -- no mitigation discussed in source.","labels":["industry"],"sourceUrl":"https://openai.com/index/openai-to-acquire-orchestra-bio","publishedAt":"2026-10-20T00:00:00.000Z","cveId":null,"cweIds":null,"cvssScore":null,"cvssSeverity":null,"severity":"info","attackType":[],"issueType":"news","affectedPackages":null,"affectedPackageNames":null,"affectedPackageRefs":null,"affectedVendors":["OpenAI"],"affectedVendorsRaw":["OpenAI","Orchestra Bio","Rosalind","GPT-Rosalind","Rosalind Workbench","Novo Nordisk","Moderna"],"classifierModel":"claude-haiku-5-5","classifierPromptVersion":"v4","summaryPromptVersion":"v2","headline":null,"headlinePromptVersion":null,"cvssVector":null,"attackVector":null,"attackComplexity":null,"privilegesRequired":null,"userInteraction":null,"exploitMaturity":null,"epssScore":null,"epssCheckedAt":null,"kevDateAdded":null,"advisoryAliases":null,"affectedPackagesSource":null,"affectedPackagesCheckedAt":null,"patchAvailable":null,"disclosureDate":"2026-10-20T00:00:00.000Z","capecIds":null,"crossRefCount":0,"attackSophistication":"moderate","impactType":null,"aiComponentTargeted":null,"llmSpecific":true,"classifierConfidence":0.95,"researchCategory":null,"atlasIds":null}}